Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.

Intra-CSF TOPO, with focal RT as needed for symptomatic areas of enhancement produced durable clearing of CSF malignant cells in 48% of patients positive at baseline, with promising median PFS and OS.